Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1986 Jun;77(6):1817–1823. doi: 10.1172/JCI112507

Identification and characterization of specific binding proteins for growth hormone in normal human sera.

A C Herington, S Ymer, J Stevenson
PMCID: PMC370539  PMID: 3711337

Abstract

The well-recognized "big" forms (45,000-100,000 mol wt) of immunoreactive human growth hormone (hGH) in human serum have been reported to be random aggregates or formal polymers. However, we have now investigated the possibility that they are protein-bound forms. After incubation of monomeric 125I-hGH with normal serum, gel chromatography indicated a peak of bound 125I-hGH (at approximately 120,000 mol wt), which was completely displaced by excess unlabeled hGH. When serum alone was chromatographed two peaks of specific binding were subsequently detected, the major peak, eluting between 74,000 and 85,000 mol wt corresponded to the 125I-hGH-binding protein complex observed at approximately 120,000 mol wt. Using a mini-gel filtration system for separating bound from free hormone, binding of 125I-hGH by normal human serum was dependent on time (equilibrium was reached in 2 h at 21 degrees C), temperature (21 degrees C greater than 37 degrees C), Ca2+ and serum concentrations. Binding was reversible and highly specific for hGH, not being displayed by GH or prolactins from several species. Scatchard analysis revealed linear plots with an affinity (KA) of 0.32 +/- 0.06 X 10(9) M-1 (n = 7). Human serum with low endogenous hGH levels, when added to rabbit liver membranes, decreased the binding of 125I-hGH in this tissue in a dose-dependent manner. These data indicate that human sera contain a specific, high affinity binding protein for hGH and that this may account, at least in part, for the known size heterogeneity of GH in serum. Its effect on GH binding to target tissues may indicate a role for the binding protein in the regulation of GH action.

Full text

PDF
1817

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Antoniades H. N. Conversion of [125I]growth hormone into high molecular weight forms in vivo. Endocrinology. 1975 Mar;96(3):799–802. doi: 10.1210/endo-96-3-799. [DOI] [PubMed] [Google Scholar]
  2. Bala R. M., Ferguson K. A., Beck J. C. Plasma biological and immunoreactive human growth hormone-like activity. Endocrinology. 1970 Sep;87(3):506–516. doi: 10.1210/endo-87-3-506. [DOI] [PubMed] [Google Scholar]
  3. Beitins I. Z., Rattazzi M. C., MacGillivray M. H. Conversion of radiolabeled human growth hormone into higher molecular weight moieties in human plasma in vivo and in vitro. Endocrinology. 1977 Aug;101(2):350–359. doi: 10.1210/endo-101-2-350. [DOI] [PubMed] [Google Scholar]
  4. Benveniste R., Stachura M. E., Szabo M., Frohman L. A. Big growth hormone (GH): conversion to small GH without peptide bond cleavage. J Clin Endocrinol Metab. 1975 Aug;41(2):422–425. doi: 10.1210/jcem-41-2-422. [DOI] [PubMed] [Google Scholar]
  5. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  6. COLLIPP P. J., KAPLAN S. A., BOYLE D. C., SHIMIZU C. S. PROTEIN BOUND HUMAN GROWTH HORMONE. Metabolism. 1964 Jun;13:532–538. doi: 10.1016/0026-0495(64)90140-4. [DOI] [PubMed] [Google Scholar]
  7. Calvo J. C., Radicella J. P., Charreau E. H. Measurement of specific radioactivities in labelled hormones by self-displacement analysis. Biochem J. 1983 May 15;212(2):259–264. doi: 10.1042/bj2120259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Carr D., Friesen H. G. Growth hormone and insulin binding to human liver. J Clin Endocrinol Metab. 1976 Mar;42(3):484–493. doi: 10.1210/jcem-42-3-484. [DOI] [PubMed] [Google Scholar]
  9. Chawla R. K., Parks J. S., Rudman D. Structural variants of human growth hormone: biochemical, genetic, and clinical aspects. Annu Rev Med. 1983;34:519–547. doi: 10.1146/annurev.me.34.020183.002511. [DOI] [PubMed] [Google Scholar]
  10. Collipp P. J., Kaplan S. A. Interaction of 14C-labeled human and bovine growth hormone with serum proteins. Biochim Biophys Acta. 1966 Apr 25;117(2):416–423. doi: 10.1016/0304-4165(66)90093-6. [DOI] [PubMed] [Google Scholar]
  11. Dimond R. C., Wartofsky L., Rosen S. W. Heterogeneity of circulating growth hormone in acromegaly. J Clin Endocrinol Metab. 1974 Dec;39(6):1133–1137. doi: 10.1210/jcem-39-6-1133. [DOI] [PubMed] [Google Scholar]
  12. Ellis S., Vodian M. A., Grindeland R. E. Studies on the bioassayable growth hormone-like activity of plasma. Recent Prog Horm Res. 1978;34:213–238. doi: 10.1016/b978-0-12-571134-0.50009-0. [DOI] [PubMed] [Google Scholar]
  13. Goodman A. D., Tanenbaum R., Rabinowitz D. Existence of two forms of immunoreactive growth hormone in human plasma. J Clin Endocrinol Metab. 1972 Dec;35(6):868–878. doi: 10.1210/jcem-35-6-868. [DOI] [PubMed] [Google Scholar]
  14. Gorden P., Hendricks C. M., Roth J. Evidence for "big" and "little" components of human plasma and pituitary growth hormone. J Clin Endocrinol Metab. 1973 Jan;36(1):178–184. doi: 10.1210/jcem-36-1-178. [DOI] [PubMed] [Google Scholar]
  15. Gorden P., Lesniak M. A., Eastman R., Hendricks C. M., Roth J. Evidence for higher proportion of "little" growth hormone with increased radioreceptor activity in acromegalic plasma. J Clin Endocrinol Metab. 1976 Aug;43(2):364–373. doi: 10.1210/jcem-43-2-364. [DOI] [PubMed] [Google Scholar]
  16. HADDEN D. R., PROUT T. E. A GROWTH HORMONE BINDING PROTEIN IN NORMAL HUMAN SERUM. Nature. 1964 Jun 27;202:1342–1343. doi: 10.1038/2021342a0. [DOI] [PubMed] [Google Scholar]
  17. Hendricks C. M., Eastman R. C., Takeda S., Asakawa K., Gorden P. Plasma clearance of intravenously administered pituitary human growth hormone: gel filtration studies of heterogeneous components. J Clin Endocrinol Metab. 1985 May;60(5):864–867. doi: 10.1210/jcem-60-5-864. [DOI] [PubMed] [Google Scholar]
  18. Herington A. C., Cornell H. J., Kuffer A. D. Recent advances in the biochemistry and physiology of the insulin-like growth factor/somatomedin family. Int J Biochem. 1983;15(10):1201–1210. doi: 10.1016/0020-711x(83)90208-2. [DOI] [PubMed] [Google Scholar]
  19. Herington A. C., Elson D., Ymer S. Water soluble receptors for human growth hormone from rabbit liver. J Recept Res. 1981;2(2):203–220. doi: 10.3109/10799898109039261. [DOI] [PubMed] [Google Scholar]
  20. Hung C. H., Kover K., Moore W. V. Characteristics of somatotropic growth hormone binding to homologous liv plasma membranes. Mol Cell Endocrinol. 1985 Mar;39(3):189–196. doi: 10.1016/0303-7207(85)90062-0. [DOI] [PubMed] [Google Scholar]
  21. Lesniak M. A., Gorden P., Roth J., Gavin J. R., 3rd Binding of 125I-human growth hormone to specific receptors in human cultured lymphocytes. Characterization of the interaction and a sensitive radioreceptor assay. J Biol Chem. 1974 Mar 25;249(6):1661–1667. [PubMed] [Google Scholar]
  22. Lewis U. J., Singh R. N., Tutwiler G. F., Sigel M. B., VanderLaan E. F., VanderLaan W. P. Human growth hormone: a complex of proteins. Recent Prog Horm Res. 1980;36:477–508. doi: 10.1016/b978-0-12-571136-4.50019-x. [DOI] [PubMed] [Google Scholar]
  23. Lewis U. J. Variants of growth hormone and prolactin and their posttranslational modifications. Annu Rev Physiol. 1984;46:33–42. doi: 10.1146/annurev.ph.46.030184.000341. [DOI] [PubMed] [Google Scholar]
  24. Lindahl A., Edén S., Albertsson-Wikland K., Isaksson O., Kostyo J. L. Relationship between the biological and immunological activities of growth hormone circulating in normal rats. Endocrinology. 1983 Jun;112(6):2054–2058. doi: 10.1210/endo-112-6-2054. [DOI] [PubMed] [Google Scholar]
  25. MacMillan D. R., Schmid J. M., Eash S. A., Read C. H. Studies on the heterogeneity and serum binding of human growth hormone. J Clin Endocrinol Metab. 1967 Aug;27(8):1090–1094. doi: 10.1210/jcem-27-8-1090. [DOI] [PubMed] [Google Scholar]
  26. Mills J. B., Kostyo J. L., Reagan C. R., Wagner S. A., Moseley M. H., Wilhelmi A. E. Fragments of human growth hormone produced by digestion with thrombin: chemistry and biological properties. Endocrinology. 1980 Aug;107(2):391–399. doi: 10.1210/endo-107-2-391. [DOI] [PubMed] [Google Scholar]
  27. Murphy L. J., Vrhovsek E., Lazarus L. Identification and characterization of specific growth hormone receptors in cultured human fibroblasts. J Clin Endocrinol Metab. 1983 Dec;57(6):1117–1124. doi: 10.1210/jcem-57-6-1117. [DOI] [PubMed] [Google Scholar]
  28. Nortier J. W., Croughs R. J., Donker G. H., Thijssen J. H., Schwarz F. Changes of molecular forms of growth hormone in bromocriptine treated acromegaly in relation to changes of somatomedin-C and clinical response. Acta Endocrinol (Copenh) 1985 Feb;108(2):145–150. doi: 10.1530/acta.0.1080145. [DOI] [PubMed] [Google Scholar]
  29. Peeters S., Friesen H. G. A growth hormone binding factor in the serum of pregnant mice. Endocrinology. 1977 Oct;101(4):1164–1183. doi: 10.1210/endo-101-4-1164. [DOI] [PubMed] [Google Scholar]
  30. Raines E. W., Bowen-Pope D. F., Ross R. Plasma binding proteins for platelet-derived growth factor that inhibit its binding to cell-surface receptors. Proc Natl Acad Sci U S A. 1984 Jun;81(11):3424–3428. doi: 10.1073/pnas.81.11.3424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Salacinski P. R., McLean C., Sykes J. E., Clement-Jones V. V., Lowry P. J. Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenyl glycoluril (Iodogen). Anal Biochem. 1981 Oct;117(1):136–146. doi: 10.1016/0003-2697(81)90703-x. [DOI] [PubMed] [Google Scholar]
  32. Shooter E. M., Yankner B. A., Landreth G. E., Sutter A. Biosynthesis and mechanism of action of nerve growth factor. Recent Prog Horm Res. 1981;37:417–446. doi: 10.1016/b978-0-12-571137-1.50013-x. [DOI] [PubMed] [Google Scholar]
  33. Singh R. N., Seavey B. K., Rice V. P., Lindsey T. T., Lewis U. J. Modified forms of human growth hormone with increased biological activities. Endocrinology. 1974 Mar;94(3):883–891. doi: 10.1210/endo-94-3-883. [DOI] [PubMed] [Google Scholar]
  34. Smith G. L. Somatomedin carrier proteins. Mol Cell Endocrinol. 1984 Feb;34(2):83–89. doi: 10.1016/0303-7207(84)90058-3. [DOI] [PubMed] [Google Scholar]
  35. Soman V., Goodman A. D. Studies of the composition and radioreceptor activity of "big" and "little" human growth hormone. J Clin Endocrinol Metab. 1977 Mar;44(3):569–581. doi: 10.1210/jcem-44-3-569. [DOI] [PubMed] [Google Scholar]
  36. Stolar M. W., Amburn K., Baumann G. Plasma "big" and "big-big" growth hormone (GH) in man: an oligomeric series composed of structurally diverse GH monomers. J Clin Endocrinol Metab. 1984 Aug;59(2):212–218. doi: 10.1210/jcem-59-2-212. [DOI] [PubMed] [Google Scholar]
  37. Stolar M. W., Baumann G., Vance M. L., Thorner M. O. Circulating growth hormone forms after stimulation of pituitary secretion with growth hormone-releasing factor in man. J Clin Endocrinol Metab. 1984 Aug;59(2):235–239. doi: 10.1210/jcem-59-2-235. [DOI] [PubMed] [Google Scholar]
  38. TOUBER J. L., MAINGAY D. Heterogeneity of human growth hormone. Its influence on a radio-immunoassay of the hormone in serum. Lancet. 1963 Jun 29;1(7296):1403–1405. doi: 10.1016/s0140-6736(63)92054-3. [DOI] [PubMed] [Google Scholar]
  39. Tokuhiro E., Dean H. J., Friesen H. G., Rudman D. Comparative study of serum human growth hormone measurement with NB2 lymphoma cell bioassay, IM-9 receptor modulation assay, and radioimmunoassay in children with disorders of growth. J Clin Endocrinol Metab. 1984 Mar;58(3):549–554. doi: 10.1210/jcem-58-3-549. [DOI] [PubMed] [Google Scholar]
  40. Tsushima T., Sasaki N., Imai Y., Matsuzaki F., Friesen H. G. Characteristics of solubilized human-somatotropin-binding protein from the liver of pregnant rabbits. Biochem J. 1980 May 1;187(2):479–492. doi: 10.1042/bj1870479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Valenta L. J., Sigel M. B., Lesniak M. A., Elias A. N., Lewis U. J., Friesen H. G., Kershnar A. K. Pituitary dwarfism in a patient with circulating abnormal growth hormone polymers. N Engl J Med. 1985 Jan 24;312(4):214–217. doi: 10.1056/NEJM198501243120405. [DOI] [PubMed] [Google Scholar]
  42. Wright D. R., Goodman A. D., Trimble K. D. Studies on "big" growth hormone from human plasma and pituitary. J Clin Invest. 1974 Nov;54(5):1064–1073. doi: 10.1172/JCI107850. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Yadley R. A., Chrambach A. Isohormones of human growth hormone. II. Plasmin-catalyzed transformation and increase in prolactin biological activity. Endocrinology. 1973 Oct;93(4):858–865. doi: 10.1210/endo-93-4-858. [DOI] [PubMed] [Google Scholar]
  44. Ymer S. I., Herington A. C. Evidence for the specific binding of growth hormone to a receptor-like protein in rabbit serum. Mol Cell Endocrinol. 1985 Jul;41(2-3):153–161. doi: 10.1016/0303-7207(85)90018-8. [DOI] [PubMed] [Google Scholar]
  45. Ymer S. I., Stevenson J. L., Herington A. C. Identification of a rabbit liver cytosolic binding protein for human growth hormone. Biochem J. 1984 Aug 1;221(3):617–622. doi: 10.1042/bj2210617. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES